Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07521059) titled 'Short-Term Safety of Low-Dose Creatine Hydrochloride: A 28-Day Single-Arm Pilot Study' on April 2.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).
Primary Sponsor: Vireo Systems, Inc.
Condition:
Safety of Short Term Creatine Hydrochloride Dosing
Intervention:
Dietary Supplement: creatine supplementation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 30, 2024
Target Sample Size: 11
Countries of Recruitment:
United States
To know more, visit https://...